All In MedTech

Device Trial Radar · NCT03723408

Factors Increasing Air Burden in Intravenous Tubing

A Prospective Observational Study of Air Burden in Intravenous Tubing: Factors That Increase Patient Risk

Last checked: Nov 20, 2026Latest source record: Oct 29, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

120

Actual

Start

Aug 16, 2016

Primary completion

Dec 21, 2017

Study completion Dec 21, 2017

Sponsor

Lead sponsor
ClearLine MDNot on our public-company list
Sponsor type
Industry
First posted
Oct 29, 2018

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Prevention
FDA-regulated device
Yes
Who can join
All sexes
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

There is widespread acceptance that air in intravenous (IV) fluid tubing (lines) can pose a significant risk to patients.1 A rigorous literature search regarding sources of this air identified only anecdotal and non-clinical work regarding the presence and sources of air in IV tubing. Most published case studies have focused on air entrainment from accidental or inadvertent sources - empty IV fluid bags, incomplete priming of the tubing prior to infusion, and air-detection device failures, as examples. The sources (and volume) of air inside IV tubing during common surgical procedures or interventions have yet to be studied prospectively. Understanding the frequency and magnitude of the presence of unintended air in IV tubing is the first step in devising potential avoidance strategies for eliminating unintended air in IV tubing. This study was designed to identify both the sources and magnitude of air that occurs in IV tubing during routine surgical procedures.

Conditions

  • Air Embolism
  • Air Leakage
  • Air Burden

Interventions

  • ClearLine IV (formerly, AirPurge)Device

    Patient safety device that automatically and continuously detects and actively removes air from IV lines - protecting patients from dangerous air burden, air embolism, air infusions.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The frequency of air removed from intravenous tubing by ClearLine IVTime frame: 1 year
  2. The amount of air removed from intravenous tubing by ClearLine IVTime frame: 1 year

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.